Novo Nordisk, Inc. | Novo Holdings A/S | Maryland | state | 2012 | $8,737 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2009 | $7,887 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2008 | $7,587 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2012 | $5,264 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | Maryland | state | 2005 | $4,398 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2004 | $3,426 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2004 | $2,732 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | Maryland | state | 2004 | $1,884 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2012 | $1,480 | | tax credit/rebate |
Astellas Pharma US, Inc. | Astellas Pharma | Maryland | state | 2007 | $1,236 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2005 | $1,205 | | tax credit/rebate |
Roxane Laboratories, Inc. et al. | Hikma Pharmaceuticals | Ohio | state | 1994 | undisclosed | | tax credit/rebate |
Ben Venue Laboratories, Inc. | Boehringer Ingelheim | Ohio | state | 1999 | undisclosed | | tax credit/rebate |
Anda Pharmaceuticals, Inc. | AbbVie | Ohio | state | 2001 | undisclosed | | tax credit/rebate |
Roxane Laboratories, Inc. et al. | Hikma Pharmaceuticals | Ohio | state | 2002 | undisclosed | | tax credit/rebate |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2004 | undisclosed | | tax credit/rebate |
Abbott Laboratories, Ross Products Division | Abbott Laboratories | Ohio | state | 2006 | undisclosed | | tax credit/rebate |
Genentech Inc | Roche | Oregon | state | 2013 | $3,340,842 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | 2013 | $100,000 | | tax credit/rebate |
Alexion Pharmaceuticals | AstraZeneca | Rhode Island | state | 2013 | undisclosed | | tax credit/rebate |
ETHICON ENDO-SURGERY INC | Johnson & Johnson | New Mexico | state | 2012 | $281,091 | | tax credit/rebate |
Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical | California | state | 2014 | $2,100,000 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | California | state | 2014 | $1,000,000 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2012 | $70,422 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2012 | $41,418 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $47,245 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2012 | $108,730 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2012 | $4,408 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2012 | $219,157 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,023 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $19,311 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2012 | $106,749 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $101,569 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2012 | $11,724 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2012 | $53,148 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2012 | $44,191 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2012 | $19,669 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2012 | $13,467 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2012 | $102,839 | | tax credit/rebate |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $45,000 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $147,996 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $150,000 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2013 | $160,000 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2013 | $170,504 | | tax credit/rebate |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $200,000 | | tax credit/rebate |
Foundation Medicine, Inc. | Roche | Massachusetts | state | 2013 | $300,309 | | tax credit/rebate |
Epizyme, Inc. | Epizyme | Massachusetts | state | 2013 | $416,500 | | tax credit/rebate |
Merrimack Pharmaceuticals, Inc | Merrimack Pharmaceuticals | Massachusetts | state | 2013 | $490,000 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $750,000 | | tax credit/rebate |
Synageva BioPharma Corp | AstraZeneca | Massachusetts | state | 2013 | $784,000 | | tax credit/rebate |
ARIAD Pharmaceuticals, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2013 | $1,225,000 | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2013 | $1,421,000 | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $1,715,000 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | Massachusetts | state | 2013 | $5,512,500 | | tax credit/rebate |
Depuy Mitek, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $68,023 | | tax credit/rebate |
Codman & Shurtleff, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $115,391 | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $43,223 | | tax credit/rebate |
Cambridge Major Laboratories, Inc. | Alcami | Wisconsin | state | 2014 | $800,000 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $1,441 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2013 | $3,605 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2013 | $4,304 | | tax credit/rebate |
IMMUNE DESIGN CORP | Merck | Washington | state | 2013 | $9,868 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $13,467 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2013 | $17,655 | | tax credit/rebate |
ONCOTHYREON INC | Seattle Genetics Inc. | Washington | state | 2013 | $19,669 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2013 | $41,681 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2013 | $44,191 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2013 | $48,418 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2013 | $62,739 | | tax credit/rebate |
SANOFI AVENTIS US LLC | Sanofi | Washington | state | 2013 | $70,422 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2013 | $102,839 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2013 | $141,588 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2013 | $298,709 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2014 | $1,480 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2014 | $5,264 | | tax credit/rebate |
Medimmune, LLC | AstraZeneca | Maryland | state | 2014 | $1,497,096 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2014 | $39,722 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2014 | $60,651 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2014 | $50,617 | | tax credit/rebate |
Astellas US Holding, Inc. | Astellas Pharma | Maryland | state | 2014 | $74,558 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Maryland | state | 2014 | $8,737 | | tax credit/rebate |
Emergent Biosolutions Inc. | Emergent BioSolutions | Maryland | state | 2014 | $103,503 | | tax credit/rebate |
MacroGenics, Inc. | MacroGenics | Maryland | state | 2014 | $80,651 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2014 | $59,756 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2014 | $50,570 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2014 | $42,268 | | tax credit/rebate |
C3i, Inc. | Merck | Pennsylvania | state | | $512,000 | | tax credit/rebate |
CSL Behring | CSL Limited | Pennsylvania | state | | $339,000 | | tax credit/rebate |
Spark Therapeutics Inc | Roche | Pennsylvania | state | | $201,000 | | tax credit/rebate |
Kite Pharma, Inc. | Gilead Sciences | California | state | 2015 | $1,800,000 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2013 | $5,485,485 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Pennsylvania | state | 2013 | $5,019,493 | | tax credit/rebate |
Janssen Research & Development, LLC ( f/k/a J&J Pharmaceutical Research & Development LLC) | Johnson & Johnson | Pennsylvania | state | 2013 | $3,468,471 | | tax credit/rebate |
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2013 | $2,357,066 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2013 | $973,073 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2013 | $656,436 | | tax credit/rebate |
Auxilium Pharmacueticals, Inc. | Endo International | Pennsylvania | state | 2013 | $465,755 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2013 | $369,915 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2013 | $345,642 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2013 | $319,819 | | tax credit/rebate |
Shire US Holdings, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2013 | $255,775 | | tax credit/rebate |